These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25360710)

  • 1. Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
    Haugum K; Johansen J; Gabrielsen C; Brandal LT; Bergh K; Ussery DW; Drabløs F; Afset JE
    PLoS One; 2014; 9(10):e111788. PubMed ID: 25360710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA; Zhang C; Bard JE; Yergeau D; Halasa N; Gómez-Duarte OG
    BMC Genomics; 2020 Aug; 21(1):564. PubMed ID: 32807093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018.
    Matussek A; Mernelius S; Chromek M; Zhang J; Frykman A; Hansson S; Georgieva V; Xiong Y; Bai X
    Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):771-779. PubMed ID: 37103716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing
    Hua Y; Chromek M; Frykman A; Jernberg C; Georgieva V; Hansson S; Zhang J; Marits AK; Wan C; Matussek A; Bai X
    Virulence; 2021 Dec; 12(1):1296-1305. PubMed ID: 33939581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.
    Naseer U; Løbersli I; Hindrum M; Bruvik T; Brandal LT
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1613-1620. PubMed ID: 28391537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.
    Brandal LT; Wester AL; Lange H; Løbersli I; Lindstedt BA; Vold L; Kapperud G
    BMC Infect Dis; 2015 Aug; 15():324. PubMed ID: 26259588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Characterization of Intimin Gene (
    Wang L; Bai X; Ylinen E; Zhang J; Saxén H; Matussek A
    Toxins (Basel); 2023 Nov; 15(12):. PubMed ID: 38133173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of human Shiga toxin-producing
    Usein CR; Ciontea AS; Militaru CM; Condei M; Dinu S; Oprea M; Cristea D; Michelacci V; Scavia G; Zota LC; Zaharia A; Morabito S
    Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.
    Kuehne A; Bouwknegt M; Havelaar A; Gilsdorf A; Hoyer P; Stark K; Werber D;
    Epidemiol Infect; 2016 Nov; 144(15):3305-3315. PubMed ID: 27468812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains.
    Coombes BK; Wickham ME; Mascarenhas M; Gruenheid S; Finlay BB; Karmali MA
    Appl Environ Microbiol; 2008 Apr; 74(7):2153-60. PubMed ID: 18245257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement.
    Newton HJ; Sloan J; Bulach DM; Seemann T; Allison CC; Tauschek M; Robins-Browne RM; Paton JC; Whittam TS; Paton AW; Hartland EL
    Emerg Infect Dis; 2009 Mar; 15(3):372-80. PubMed ID: 19239748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
    Werber D; Fruth A; Buchholz U; Prager R; Kramer MH; Ammon A; Tschäpe H
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):726-30. PubMed ID: 14614596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years.
    Haugum K; Brandal LT; Lindstedt BA; Wester AL; Bergh K; Afset JE
    J Clin Microbiol; 2014 Sep; 52(9):3156-63. PubMed ID: 24920783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing
    Bruyand M; Mariani-Kurkdjian P; Le Hello S; King LA; Van Cauteren D; Lefevre S; Gouali M; Jourdan-da Silva N; Mailles A; Donguy MP; Loukiadis E; Sergentet-Thevenot D; Loirat C; Bonacorsi S; Weill FX; De Valk H;
    Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand.
    Leotta GA; Miliwebsky ES; Chinen I; Espinosa EM; Azzopardi K; Tennant SM; Robins-Browne RM; Rivas M
    BMC Microbiol; 2008 Mar; 8():46. PubMed ID: 18366637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
    Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
    Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
    J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.